Enabling better health outcomes from infectious diseases through rapid diagnostics
Recognition
BioAlberta
Technology Innovation of the Year Award (2025)
Scale Up Canada
Calgary50: Most Scalable Startups (2025 and 2026)
RESI JPM 2026
Judges' Pick, Innovator's Pitch Challenge
Rapid Infection Diagnostics (RID) Inc. was founded in August of 2019 with a mission of reducing death and disability from infectious diseases via state-of-the-art diagnostic technology.
RID Inc. leverages advanced mass spectrometry to enable a suite of rapid diagnostic tests that reduce microbiology testing times from days to hours.
RID’s mission is to save lives through RAPID microbial analysis.
RID technology enables the fastest and most comprehensive microbiology testing workflow for large microbiology laboratories.
RID Technology
Our team has developed the RID Rapid Analyzer, a rapid, high-throughput metabolomics-based system for microbial identification (ID) and antimicrobial susceptibility testing (AST) in a single run. You can also view our existing patents here.
“The impact of RID technologies will be measured in thousands of lives and millions of dollars saved annually.”
Dr. Ian Lewis, CEO & Founder